Advertisement

Laparoscopic Renal Ablation

  • Gaurav Bandi
  • Stephen Y. Nakada
Part of the Current Clinical Urology book series (CCU)

Abstract

Nephron sparing surgery (NSS) is accepted as the treatment of choice in patients with solitary kidney, bilateral renal masses, and in patients with renal insufficiency (1,2). In patients with renal tumors less than 4 cm and a normal contralateral kidney, NSS has been shown to have a decreased incidence of long-term renal insufficiency (2). It has also been associated with an improved quality of life (3,4). Open partial nephrectomy (OPN) is the gold standard treatment for NSS. Laparoscopic partial nephrectomy (LPN) has recently been popularized by Gill and associates (5). Although LPN has been shown to have good oncologic outcomes at an intermediate follow-up (6); it requires advanced laparoscopic skills and has associated perioperative morbidity (7,8). A recent large multicenter retrospective study compared the perioperative outcomes between open and laparoscopic partial nephrectomy (9). LPN was associated with shorter operative time, decreased operative blood loss, and shorter hospital stay. Although, the incidence of intraoperative complications was comparable in the two groups LPN was associated with longer ischemia time, more postoperative complications (particularly urological), and an increased number of subsequent procedures. Overall 25.2% of patients undergoing LPN had a postoperative complication compared to 19.8% who underwent OPN. After 3 months, renal functional outcomes for laparoscopic and open partial nephrectomy were similar.

Keywords

Renal Tumor Partial Nephrectomy Laparoscopic Partial Nephrectomy Transperitoneal Approach Open Partial Nephrectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. The Journal of Urology. 2000 Feb: 163:442–445CrossRefPubMedGoogle Scholar
  2. 2.
    Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clinic Proceedings. 2000 Dec: 75:1236–1242CrossRefPubMedGoogle Scholar
  3. 3.
    Clark PE, Schover LR, Uzzo RG, Hafez KS, Rybicki LA, Novick AC. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology. 2001 Feb: 57:252–256CrossRefPubMedGoogle Scholar
  4. 4.
    Shinohara N, Harabayashi T, Sato S, Hioka T, Tsuchiya K, Koyanagi T. Impact of nephron-sparing surgery on quality of life in patients with localized renal cell carcinoma. European urology. 2001 Jan: 39:114–119CrossRefPubMedGoogle Scholar
  5. 5.
    Moinzadeh A, Gill IS, Finelli A, Kaouk J, Desai M. Laparoscopic partial nephrectomy: 3-year followup. The Journal of Urology. 2006 Feb: 175:459–462CrossRefPubMedGoogle Scholar
  6. 6.
    Lane BR, Gill IS. 5-Year outcomes of laparoscopic partial nephrectomy. The Journal of Urology. 2007 Jan: 177:70–74; discussion 4CrossRefPubMedGoogle Scholar
  7. 7.
    Gill IS, Matin SF, Desai MM, et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. The Journal of Urology. 2003 Jul: 170:64–68CrossRefPubMedGoogle Scholar
  8. 8.
    Ramani AP, Desai MM, Steinberg AP, et al. Complications of laparoscopic partial nephrectomy in 200 cases. The Journal of Urology. 2005 Jan: 173:42–47CrossRefPubMedGoogle Scholar
  9. 9.
    Gill IS, Kavoussi LR, Lane BR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. The Journal of Urology. 2007 Jul: 178:41–46CrossRefPubMedGoogle Scholar
  10. 10.
    Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program. The Journal of Urology. 2006 Dec: 176:2397–2400; discussion 400CrossRefPubMedGoogle Scholar
  11. 11.
    Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998 Feb: 51:203–205CrossRefPubMedGoogle Scholar
  12. 12.
    Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982–1997). Urology. 2000 Jul: 56:58–62CrossRefPubMedGoogle Scholar
  13. 13.
    Uchida M, Imaide Y, Sugimoto K, Uehara H, Watanabe H. Percutaneous cryosurgery for renal tumours. British Journal of Urology. 1995 Feb: 75:132–136; discussion 6–7CrossRefPubMedGoogle Scholar
  14. 14.
    Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984 Sep: 247:C125–C142PubMedGoogle Scholar
  15. 15.
    Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002 Aug: 60:40–49CrossRefPubMedGoogle Scholar
  16. 16.
    Daum PS, Bowers WD, Jr., Tejada J, Hamlet MP. Vascular casts demonstrate microcirculatory insufficiency in acute frostbite. Cryobiology. 1987 Feb: 24:65–73CrossRefPubMedGoogle Scholar
  17. 17.
    Yang WL, Addona T, Nair DG, Qi L, Ravikumar TS. Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. International Journal of Cancer. 2003 Jan 20: 103:360–369CrossRefGoogle Scholar
  18. 18.
    Baust JG, Gage AA. The molecular basis of cryosurgery. BJU International. 2005 Jun: 95:1187–1191CrossRefPubMedGoogle Scholar
  19. 19.
    Chosy SG, Nakada SY, Lee FT, Jr., Warner TF. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. The Journal of Urology. 1998 Apr: 159:1370–1374CrossRefPubMedGoogle Scholar
  20. 20.
    Woolley ML, Schulsinger DA, Durand DB, Zeltser IS, Waltzer WC. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. Journal of Endourology/Endourological Society. 2002 Sep: 16:519–522CrossRefPubMedGoogle Scholar
  21. 21.
    Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. Journal of Endourology/Endourological Society. 1997 Aug: 11:251–258CrossRefPubMedGoogle Scholar
  22. 22.
    Yohannes P, Pinto P, Rotariu P, Smith AD, Lee BR. Retroperitoneoscopic radiofrequency ablation of a solid renal mass. Journal of Endourology/Endourological Society. 2001 Oct: 15:845–849CrossRefPubMedGoogle Scholar
  23. 23.
    Matlaga BR, Zagoria RJ, Clark PE, Hall MC. Radiofrequency ablation of renal tumors. Current Urology Reports. 2004 Feb: 5:39–44CrossRefPubMedGoogle Scholar
  24. 24.
    Bhowmick P, Coad JE, Bhowmick S, et al. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. International Journal of Hyperthermia. 2004 Jun: 20:421–439CrossRefPubMedGoogle Scholar
  25. 25.
    Bhowmick S, Coad JE, Swanlund DJ, Bischof JC. In vitro thermal therapy of AT-1 Dunning prostate tumours. International Journal of Hyperthermia. 2004 Feb: 20:73–92CrossRefPubMedGoogle Scholar
  26. 26.
    Rehman J, Landman J, Lee D, et al. Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. Journal of Endourology/Endourological Society. 2004 Feb: 18:83–104CrossRefPubMedGoogle Scholar
  27. 27.
    Davol PE, Fulmer BR, Rukstalis DB. Long-term results of cryoablation for renal cancer and complex renal masses. Urology. 2006 Jul: 68:2–6CrossRefPubMedGoogle Scholar
  28. 28.
    Stein RJ, Kaouk JH. Renal cryotherapy: a detailed review including a 5-year follow-up. BJU international. 2007 May: 99:1265–1270CrossRefPubMedGoogle Scholar
  29. 29.
    Desai MM, Aron M, Gill IS. Laparoscopic partial nephrectomy versus laparoscopic cryoablation for the small renal tumor. Urology. 2005 Nov: 66:23–28CrossRefPubMedGoogle Scholar
  30. 30.
    Brashears JH, 3rd, Raj GV, Crisci A, et al. Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. The Journal of Urology. 2005 Jun: 173:2160–2165CrossRefPubMedGoogle Scholar
  31. 31.
    Janzen NK, Perry KT, Han KR, et al. The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. The Journal of Urology. 2005 Apr: 173:1368–1374CrossRefPubMedGoogle Scholar
  32. 32.
    Klingler HC, Marberger M, Mauermann J, Remzi M, Susani M. 'Skipping' is still a problem with radiofrequency ablation of small renal tumours. BJU International. 2007 May: 99:998–1001CrossRefPubMedGoogle Scholar
  33. 33.
    Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology. 2006 Jul: 68:7–13CrossRefPubMedGoogle Scholar
  34. 34.
    Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. The Journal of Urology. 2006 Nov: 176:1973–1977CrossRefPubMedGoogle Scholar
  35. 35.
    Bandi G, Wen CC, Hedican SP, Moon TD, Lee FT, Jr., Nakada SY. Cryoablation of small renal masses: assessment of the outcome at one institution. BJU International. 2007 Oct: 100:798–801CrossRefPubMedGoogle Scholar
  36. 36.
    Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: intermediate-term results. Journal of Endourology / Endourological Society. 2006 Aug: 20:569–573CrossRefPubMedGoogle Scholar
  37. 37.
    Shingleton WB, Sewell PE, Jr. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. The Journal of Urology. 2001 Mar: 165:773–776CrossRefPubMedGoogle Scholar
  38. 38.
    Johnson DB, Solomon SB, Su LM, et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. The Journal of Urology. 2004 Sep: 172:874–877CrossRefPubMedGoogle Scholar
  39. 39.
    Margulis V, Matsumoto ED, Lindberg G, et al. Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation. Urology. 2004 Oct: 64:660–663CrossRefPubMedGoogle Scholar
  40. 40.
    Hegarty NJ, Kaouk J, Remer EM, O'Malley CM, Novick AC, Gill IS. Lack of enhancement on 6-month MRI does not guarantee complete cancer cell kill following radiofrequency ablation of small renal tumors. The Journal of Urology. 2006: 175 (Suppl):552CrossRefGoogle Scholar
  41. 41.
    Michaels MJ, Rhee HK, Mourtzinos AP, Summerhayes IC, Silverman ML, Libertino JA. Incomplete renal tumor destruction using radio frequency interstitial ablation. The Journal of Urology. 2002 Dec: 168:2406–2409; discussion 9–10CrossRefPubMedGoogle Scholar
  42. 42.
    Rendon RA, Kachura JR, Sweet JM, et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. The Journal of Urology. 2002 Apr: 167:1587–1592CrossRefPubMedGoogle Scholar
  43. 43.
    Jacomides L, Ogan K, Watumull L, Cadeddu JA. Laparoscopic application of radio frequency energy enables in situ renal tumor ablation and partial nephrectomy. The Journal of Urology. 2003 Jan: 169:49–53; discussionCrossRefPubMedGoogle Scholar
  44. 44.
    Hwang JJ, Walther MM, Pautler SE, et al. Radio frequency ablation of small renal tumors: intermediate results. The Journal of Urology. 2004 May: 171:1814–1818CrossRefPubMedGoogle Scholar
  45. 45.
    Park S, Cadeddu JA. Outcomes of radiofrequency ablation for kidney cancer. Cancer Control. 2007 Jul: 14:205–210PubMedGoogle Scholar
  46. 46.
    Gill IS, Remer EM, Hasan WA, et al. Renal cryoablation: outcome at 3 years. The Journal of Urology. 2005 Jun: 173:1903–1907CrossRefPubMedGoogle Scholar
  47. 47.
    Weld KJ, Figenshau RS, Venkatesh R, et al. Laparoscopic cryoablation for small renal masses: three-year follow-up. Urology. 2007 Mar: 69:448–451CrossRefPubMedGoogle Scholar
  48. 48.
    Carvalhal EF, Gill IS, Meraney AM, Desai MM, Schweizer DK, Sung GT. Laparoscopic renal cryoablation: impact on renal function and blood pressure. Urology. 2001 Sep: 58:357–361CrossRefPubMedGoogle Scholar
  49. 49.
    Ng CS, Gill IS. Impact of renal cryoablation on urine composition. Urology. 2002 Jun: 59:831–834CrossRefPubMedGoogle Scholar
  50. 50.
    Cestari A, Guazzoni G, dell’Acqua V, Nava L, Cardone G, Balconi G, Naspro R, Montorsi F, Rigatti P. Laparoscopic cryoablation of solid renal masses: intermediate term followup. J Urol. 2004 Oct: 172(4 Pt 1):1267–70Google Scholar
  51. 51.
    Lawatsch EJ, Langenstroer P, Byrd GF, See WA, Quiroz FA, Begun FP. Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of Wisconsin. J Urol Apr: 175(4):1225–9Google Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC, a part of Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Gaurav Bandi
    • 1
  • Stephen Y. Nakada
    • 2
  1. 1.Department of UrologyThomas Jefferson University Hospital, Jefferson Medical CollegePhiladelphia
  2. 2.University of Wisconsin at MadisonMadison

Personalised recommendations